Cargando…

Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is the most common inflammatory skin disease. It is highly heterogeneous in clinical presentation, treatment response, disease trajectory and associated atopic comorbidities. Immune biomarkers are dysregulated in skin and peripheral blood. AIMS: We used noninvasive...

Descripción completa

Detalles Bibliográficos
Autores principales:	McAleer, M. A., Jakasa, I., Stefanovic, N., McLean, W. H. I., Kezic, S., Irvine, A. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359435/ https://www.ncbi.nlm.nih.gov/pubmed/33269467 http://dx.doi.org/10.1111/bjd.19703

Ejemplares similares

Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis
por: Haftek, Marek, et al.
Publicado: (2020)

Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell‐related immunity and angiogenesis
por: McAleer, M.A., et al.
Publicado: (2018)

Early‐life regional and temporal variation in filaggrin‐derived natural moisturizing factor, filaggrin‐processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis
por: McAleer, M.A., et al.
Publicado: (2018)

Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis
por: Nousbeck, Janna, et al.
Publicado: (2022)

Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis
por: Riethmuller, Christoph, et al.
Publicado: (2015)

Adhesion of Staphylococcus aureus to Corneocytes from Atopic Dermatitis Patients Is Controlled by Natural Moisturizing Factor Levels
por: Feuillie, Cécile, et al.
Publicado: (2018)

Children with atopic dermatitis show increased activity of β‐glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu
por: Kezic, Sanja, et al.
Publicado: (2022)

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
por: McAleer, Jeremy P.
Publicado: (2023)

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity
por: Kezic, S, et al.
Publicado: (2011)

Staphylococcus aureus binds to the N-terminal region of corneodesmosin to adhere to the stratum corneum in atopic dermatitis
por: Towell, Aisling M., et al.
Publicado: (2021)

The exposome in atopic dermatitis
por: Stefanovic, Nicholas, et al.
Publicado: (2019)

South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin()
por: Thawer-Esmail, Fatemah, et al.
Publicado: (2014)

The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from patients with atopic dermatitis
por: Harkins, C.P., et al.
Publicado: (2018)

Addressing topical corticosteroid phobia in atopic dermatitis: The role of the pharmacist
por: Ladda, Matthew, et al.
Publicado: (2021)

The Role of the Environment and Exposome in Atopic Dermatitis
por: Stefanovic, Nicholas, et al.
Publicado: (2021)

Cortisol Homeostasis in the Epidermis is Influenced by Topical Corticosteroids in Patients with Atopic Dermatitis
por: Fukaya, Mototsugu
Publicado: (2017)

Intragenic Copy Number Variation within Filaggrin Contributes to the Risk of Atopic Dermatitis with a Dose-Dependent Effect
por: Brown, Sara J, et al.
Publicado: (2012)

The long‐term safety of topical corticosteroids in atopic dermatitis: A systematic review
por: Harvey, Jane, et al.
Publicado: (2023)

Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency
por: Kezic, Sanja, et al.
Publicado: (2012)

Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
por: Arnold, Kathryn A., et al.
Publicado: (2018)

Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey
por: El Hachem, Maya, et al.
Publicado: (2017)

Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis—a systematic review
por: Shetty, Kshitya, et al.
Publicado: (2021)

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
por: Drucker, A.M., et al.
Publicado: (2018)

Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year
por: Kennedy, Elizabeth A., et al.
Publicado: (2017)

Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
por: Hagino, Teppei, et al.
Publicado: (2023)

Differences in Occurrence, Risk Factors and Severity of Early-onset Atopic Dermatitis among Preterm and Term Children
por: GERNER, Trine, et al.
Publicado: (2022)

Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu
por: Jurakic Toncic, Ruzica, et al.
Publicado: (2020)

Risk of skin atrophy induced by short-term topical corticosteroid use in atopic dermatitis lesional skin: A systematic review
por: Ricardo, Jose W., et al.
Publicado: (2023)

Defining the temporal relationship between the skin microbiome, immune response and skin barrier function during flare and resolution of atopic dermatitis: protocol of a Danish intervention study
por: Rønnstad, Amalie Thorsti Møller, et al.
Publicado: (2023)

Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009)

Topical steroid addiction in atopic dermatitis
por: Fukaya, Mototsugu, et al.
Publicado: (2014)

Topical Therapy in Atopic Dermatitis in Children
por: Sathishkumar, Dharshini, et al.
Publicado: (2016)

Tolerability of Topical Treatments for Atopic Dermatitis
por: Draelos, Zoe D., et al.
Publicado: (2019)

What’s New in Topicals for Atopic Dermatitis?
por: Kleinman, Elana, et al.
Publicado: (2022)

TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents
por: Moret, Leïla, et al.
Publicado: (2013)

A prospective study of atopic dermatitis managed without topical corticosteroids for a 6-month period
por: Fukaya, Mototsugu, et al.
Publicado: (2016)

A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic dermatitis
por: Wilson, F., et al.
Publicado: (2020)

Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study
por: Albogami, Maha Fayez, et al.
Publicado: (2023)

Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis
por: Fröschl, Barbara, et al.
Publicado: (2007)

Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i2oooe7lgu28m7f005vj4tjn5d